Shu-Wei Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shu-Wei Liang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Chien-Lin Chen
Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan
7 shared publications Tso-Tsai Liu
5 shared publications- Jui-Sheng Hung
Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan
4 shared publications - Chih-Hsun Yi
Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan
3 shared publications - Ming-Wun Wong
Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan
3 shared publications - Wei-Yi Lei
Department of Medicine, Buddhist Tzu Chi General Hospital, Tzu Chi University, Hualien 970, Taiwan
3 shared publications
Latest Publications
- Open Access
- 9 October 2025
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 42 (4) , e70125
Acute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults
The 5‐hydroxytryptamine type 4 receptor agonist mosapride is known to modulate esophageal peristalsis and enhance lower esophageal sphincter compliance. However, its impact on oropharyngeal swallowing physiology remains insufficiently characterized. This study aimed to investigate the acute effects of mosapride on oropharyngeal swallowing dynamics in adults. Participants received either oral mosapride (40 mg) or placebo 1 h prior to testing in a randomized, crossover design. High‐resolution impedance manometry was performed using a solid‐state catheter to measure pressure and impedance within the oropharyngeal segment. Each participant underwent at least three swallows of 5, 10, and 20 mL thin and thick liquids administered by syringe. Manometric data were analyzed using the Swallow Gateway web‐based platform. Twenty‐four volunteers (13 male, mean age, 33 years; range, 24–56 years) completed the study. During thick swallows, mosapride significantly increased upper esophageal sphincter (UES) maximal opening admittance compared to placebo (5 mL: p = 0.017; 10 mL: p = 0.008) and reduced UES integrated relaxation pressure (10 mL: p = 0.018; 20 mL: p = 0.017). No significant effects were observed during thin liquid swallows. A marginal reduction in pre‐deglutitive UES basal pressure was noted during 5 mL thick swallows ( p = 0.050). Following adjustment using repeated measures ANOVA, only the reduction in UES basal pressure remained statistically significant ( p = 0.040). Acute administration of oral mosapride results in reduced UES basal tone in adults. These findings provide novel physiological evidence suggesting that mosapride may modulate neuroregulatory mechanisms controlling UES contractility.
- 9 October 2025
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 42 (4) , e70125
Open AccessAcute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults
The 5‐hydroxytryptamine type 4 receptor agonist mosapride is known to modulate esophageal peristalsis and enhance lower esophageal sphincter compliance. However, its impact on oropharyngeal swallowing physiology remains insufficiently characterized. This study aimed to investigate the acute effects of mosapride on oropharyngeal swallowing dynamics in adults. Participants received either oral mosapride (40 mg) or placebo 1 h prior to testing in a randomized, crossover design. High‐resolution impedance manometry was performed using a solid‐state catheter to measure pressure and impedance within the oropharyngeal segment. Each participant underwent at least three swallows of 5, 10, and 20 mL thin and thick liquids administered by syringe. Manometric data were analyzed using the Swallow Gateway web‐based platform. Twenty‐four volunteers (13 male, mean age, 33 years; range, 24–56 years) completed the study. During thick swallows, mosapride significantly increased upper esophageal sphincter (UES) maximal opening admittance compared to placebo (5 mL: p = 0.017; 10 mL: p = 0.008) and reduced UES integrated relaxation pressure (10 mL: p = 0.018; 20 mL: p = 0.017). No significant effects were observed during thin liquid swallows. A marginal reduction in pre‐deglutitive UES basal pressure was noted during 5 mL thick swallows ( p = 0.050). Following adjustment using repeated measures ANOVA, only the reduction in UES basal pressure remained statistically significant ( p = 0.040). Acute administration of oral mosapride results in reduced UES basal tone in adults. These findings provide novel physiological evidence suggesting that mosapride may modulate neuroregulatory mechanisms controlling UES contractility.
- 5 July 2023
- Published by Elsevier in Gastroenterology
- Vol. 164 (6)
Su1305 ESOPHAGEAL HYPERVIGILANCE AND ANXIETY SCALE CORRELATE WITH SYMPTOMS RESPONSE IN GERD PATIENTS WITH NORMAL ACID EXPOSURE
- 5 July 2023
- Published by Elsevier in Gastroenterology
- Vol. 164 (6)
Su1305 ESOPHAGEAL HYPERVIGILANCE AND ANXIETY SCALE CORRELATE WITH SYMPTOMS RESPONSE IN GERD PATIENTS WITH NORMAL ACID EXPOSURE
- Open Access
- 17 October 2022
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 39 (1) , 80-86
Effects of the GABA(B) agonist baclofen on volitional swallowing in normal subjects
The GABA(B) receptor agonist baclofen is known to suppress the rate of spontaneous swallowing but not pharyngeal muscle contraction. The extent to which baclofen may alter volitional swallowing is not currently known. We investigated the effects of baclofen in healthy subjects, hypothesizing that baclofen exposure would alter volume-regulation and/or piecemeal deglutition behaviors during volitional swallowing attempts. Pharyngeal high-resolution manometry impedance (P-HRM-I) protocol was used to assess swallowing function of 22 healthy adult volunteers (median 29 years) who were investigated on two occasions, receiving 40 mg baclofen (oral) 1 h before study, or placebo (randomized). Standard swallow function variables recommended by the pharyngeal HRM Working Group were derived for 5 ml, 10 ml, and 20 ml volumes of thin and extremely thick liquid challenges. Multiple swallow behaviors, comprising two swallows <5 s apart, were characterized. The spontaneous swallow rate was also determined. Baclofen exposure had no overall significant effect on swallow variables. Upper esophageal sphincter pressure was weaker during exposure to baclofen, during both the pre-deglutitive and post-deglutitive phases of the swallow (p < 0.05 during thick liquid swallows). Piecemeal swallows, where the bolus is separated in two potions, were significantly more common during 20 ml boluses (p = 0.002). Baclofen decreased the frequency of piecemeal deglutition overall. Baclofen has limited to no effect on volitional swallowing measures, however, does reduce the likelihood of initiation of piecemeal deglutition to large volume challenges.
- 17 October 2022
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 39 (1) , 80-86
Open AccessEffects of the GABA(B) agonist baclofen on volitional swallowing in normal subjects
The GABA(B) receptor agonist baclofen is known to suppress the rate of spontaneous swallowing but not pharyngeal muscle contraction. The extent to which baclofen may alter volitional swallowing is not currently known. We investigated the effects of baclofen in healthy subjects, hypothesizing that baclofen exposure would alter volume-regulation and/or piecemeal deglutition behaviors during volitional swallowing attempts. Pharyngeal high-resolution manometry impedance (P-HRM-I) protocol was used to assess swallowing function of 22 healthy adult volunteers (median 29 years) who were investigated on two occasions, receiving 40 mg baclofen (oral) 1 h before study, or placebo (randomized). Standard swallow function variables recommended by the pharyngeal HRM Working Group were derived for 5 ml, 10 ml, and 20 ml volumes of thin and extremely thick liquid challenges. Multiple swallow behaviors, comprising two swallows <5 s apart, were characterized. The spontaneous swallow rate was also determined. Baclofen exposure had no overall significant effect on swallow variables. Upper esophageal sphincter pressure was weaker during exposure to baclofen, during both the pre-deglutitive and post-deglutitive phases of the swallow (p < 0.05 during thick liquid swallows). Piecemeal swallows, where the bolus is separated in two potions, were significantly more common during 20 ml boluses (p = 0.002). Baclofen decreased the frequency of piecemeal deglutition overall. Baclofen has limited to no effect on volitional swallowing measures, however, does reduce the likelihood of initiation of piecemeal deglutition to large volume challenges.
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Su1233: INFLUENCE OF CODEINE ON ESOPHAGEAL PERISTASIS IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Su1233: INFLUENCE OF CODEINE ON ESOPHAGEAL PERISTASIS IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
882: ESOPHAGEAL HYPERVIGILANCE AND VISCERAL ANXIETY CONTRIBUTE TO LARYNGOPHARYNGEAL REFLUX SYMPTOM SEVERITY IN PATIENTS WITH CONCOMITANT GERD
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
882: ESOPHAGEAL HYPERVIGILANCE AND VISCERAL ANXIETY CONTRIBUTE TO LARYNGOPHARYNGEAL REFLUX SYMPTOM SEVERITY IN PATIENTS WITH CONCOMITANT GERD
- Open Access
- 17 May 2022
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 55 (4) , 643-650
Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection
- 17 May 2022
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 55 (4) , 643-650
Open AccessImprovement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection
- Open Access
- 1 January 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121 (1) , 388-394
Esophageal acid burden in reflux patients with normal endoscopy: Does esophageal peristalsis matter?
- 1 January 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121 (1) , 388-394
Open AccessEsophageal acid burden in reflux patients with normal endoscopy: Does esophageal peristalsis matter?